News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Two U.S. Drug Safety Reviewers Urge GlaxoSmithKline (GSK)'s (JOBS) Avandia Come Off Market


2/22/2010 6:47:27 AM

Bookmark and Share

Reuters -- Two U.S. drug safety reviewers have recommended that GlaxoSmithKline PLC's diabetes drug Avandia be pulled from the market after concluding it is more dangerous to the heart than a rival medicine, according to documents released on Saturday.

Read at Reuters
Read at Wall Street Journal
Read at News Release
Read at Washington Post

comments powered by Disqus
   
Diabetes

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES